August 22, 2017 - By Adrian Erickson
Essex Investment Management Co Llc increased Axogen Inc (AXGN) stake by 59.77% reported in 2016Q4 SEC filing. Essex Investment Management Co Llc acquired 53,086 shares as Axogen Inc (AXGN)’s stock rose 35.94%. The Essex Investment Management Co Llc holds 141,909 shares with $1.28M value, up from 88,823 last quarter. Axogen Inc now has $511.90M valuation. It closed at $15.4 lastly. It is down 181.49% since August 22, 2016 and is uptrending. It has outperformed by 164.79% the S&P500.
Rubicon Tech Incorporated (NASDAQ:RBCN) had an increase of 11.93% in short interest. RBCN’s SI was 113,500 shares in August as released by FINRA. Its up 11.93% from 101,400 shares previously. With 7,000 avg volume, 16 days are for Rubicon Tech Incorporated (NASDAQ:RBCN)’s short sellers to cover RBCN’s short positions. It closed at $7.86 lastly. It is down 39.08% since August 22, 2016 and is uptrending. It has outperformed by 22.38% the S&P500.
Rubicon Technology, Inc. is a vertically integrated, electronic materials well-known provider specializing in monocrystalline sapphire for applications in light-emitting diodes , optical systems and specialty electronic devices. The company has market cap of $21.41 million. The Company’s product lines include sapphire cores; four and six-inch sapphire wafers; four, six, and eight-inch patterned sapphire substrate (PSS) wafers, and optical sapphire components. It currently has negative earnings. The Company’s sapphire is also used as an exterior component in mobile devices, specifically camera lens covers, dual flashes and home buttons on certain newer model smartphones and as the crystal covering the faces of certain smart watches.
Investors sentiment decreased to 1.4 in 2016 Q4. Its down 0.77, from 2.17 in 2016Q3. It worsened, as 2 investors sold Rubicon Technology, Inc. shares while 8 reduced holdings. 5 funds opened positions while 9 raised stakes. 10.81 million shares or 10.34% less from 12.06 million shares in 2016Q3 were reported. Moreover, Northern Tru Corporation has 0% invested in Rubicon Technology, Inc. (NASDAQ:RBCN). Bancshares Of Montreal Can holds 620 shares. 118,986 are owned by Geode Cap Mgmt Ltd Liability Corp. Morgan Stanley owns 26,044 shares. Citadel Ltd Co reported 18,484 shares. Susquehanna Intll Grp Incorporated Ltd Liability Partnership owns 24,735 shares. Raymond James Fincl Advsr Incorporated invested in 11,701 shares. California Public Employees Retirement System has invested 0% of its portfolio in Rubicon Technology, Inc. (NASDAQ:RBCN). Wolverine Asset Mgmt Ltd Liability Corporation holds 364,256 shares. Blackrock Advisors Ltd Liability, Delaware-based fund reported 5,299 shares. Wells Fargo And Co Mn holds 7,047 shares or 0% of its portfolio. Manufacturers Life The holds 388 shares or 0% of its portfolio. Blackrock Institutional Trust Co Na has invested 0% in Rubicon Technology, Inc. (NASDAQ:RBCN). Ariel Invs Limited Liability Corp reported 3.25 million shares stake. Freestone Ltd Limited Liability Company holds 12,000 shares.
Among 5 analysts covering AxoGen (NASDAQ:AXGN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AxoGen had 10 analyst reports since August 11, 2015 according to SRatingsIntel. As per Tuesday, August 11, the company rating was upgraded by Zacks. Lake Street downgraded AxoGen, Inc. (NASDAQ:AXGN) on Thursday, November 3 to “Hold” rating. The rating was upgraded by Lake Street to “Buy” on Tuesday, November 22. Wedbush maintained AxoGen, Inc. (NASDAQ:AXGN) rating on Monday, November 7. Wedbush has “Outperform” rating and $12 target. The rating was maintained by Cantor Fitzgerald on Monday, August 21 with “Buy”. On Friday, August 28 the stock rating was maintained by Wedbush with “Outperform”.
Essex Investment Management Co Llc decreased Occidental Pete Corp Del (NYSE:OXY) stake by 17,676 shares to 19,981 valued at $1.42 million in 2016Q4. It also reduced Amphastar Pharmaceuticals In (NASDAQ:AMPH) stake by 58,005 shares and now owns 63,661 shares. Newfield Expl Co (NYSE:NFX) was reduced too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.